These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34966375)

  • 1. Plant Antimicrobial Peptides as Potential Tool for Topic Treatment of Hidradenitis Suppurativa.
    Dos Santos-Silva CA; Tricarico PM; Vilela LMB; Roldan-Filho RS; Amador VC; d'Adamo AP; Rêgo MS; Benko-Iseppon AM; Crovella S
    Front Microbiol; 2021; 12():795217. PubMed ID: 34966375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.
    Harvey LM; Fortson JK
    Cureus; 2021 Oct; 13(10):e18704. PubMed ID: 34790460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa: Consequences of Microbiome Dysbiosis on Immune Dysregulation and Disease Severity.
    Chung MG; Preda-Naumescu A; Yusuf N
    Indian J Dermatol; 2022; 67(6):699-704. PubMed ID: 36998859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
    Agnese ER; Tariche N; Sharma A; Gulati R
    Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues.
    Molinelli E; De Simoni E; Candelora M; Sapigni C; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
    Antibiotics (Basel); 2023 May; 12(6):. PubMed ID: 37370297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
    Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.
    Chopra D; Arens RA; Amornpairoj W; Lowes MA; Tomic-Canic M; Strbo N; Lev-Tov H; Pastar I
    Front Immunol; 2022; 13():960488. PubMed ID: 35967376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa; classification, remedies, etiology, and comorbidities; a narrative review.
    Mohammadi S; Gholami A; Hejrati L; Rohani M; Rafiei-Sefiddashti R; Hejrati A
    J Family Med Prim Care; 2021 Nov; 10(11):4009-4016. PubMed ID: 35136760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations.
    Preda-Naumescu A; Ahmed HN; Mayo TT; Yusuf N
    Int J Dermatol; 2021 Nov; 60(11):e449-e458. PubMed ID: 33890304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
    Molinelli E; Gioacchini H; Sapigni C; Diotallevi F; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides in hidradenitis suppurativa: a systematic review.
    Yao Y; Frew JW; Thomsen SF; Ring HC
    Br J Dermatol; 2022 Feb; 186(2):236-244. PubMed ID: 34498267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on the treatment of hidradenitis suppurativa.
    Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
    Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boils at Frictional Locations in a Patient with Hidradenitis Suppurativa.
    Boer J; Mihajlovic D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):303-304. PubMed ID: 28128084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of hidradenitis suppurativa.
    Yuan JT; Naik HB
    Semin Cutan Med Surg; 2017 Jun; 36(2):79-85. PubMed ID: 28538749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities of hidradenitis suppurativa: A review of the literature.
    Cartron A; Driscoll MS
    Int J Womens Dermatol; 2019 Dec; 5(5):330-334. PubMed ID: 31909152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Hormonal Therapy in Hidradenitis Suppurativa.
    Karagaiah P; Daveluy S; Ortega-Loayza A; Gulliver W; Szepietowski J; Grabbe S; Goldust M
    J Drugs Dermatol; 2023 Apr; 22(4):369-374. PubMed ID: 37026880
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.